1. |
[Comment] Importance of investing time and money in integrating large language model-based agents into outbreak analytics pipelines |
Albert Jan van Hoek, Sebastian Funk, Stefan Flasche, Billy J Quilty, Esther van Kleef, Anton Camacho, Adam J Kucharski |
|
2. |
[Correspondence] Additional breastfeeding data essential to better understand kinetics of A (H1N1) pdm09 strain-specific antibodies induced by placental transfer and natural infection in children from birth to 3 years of age |
Yulei Li |
|
3. |
[Articles] SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial |
Brittany L Ober Shepherd, Paul T Scott, Jack N Hutter, Christine Lee, Melanie D McCauley, Ivelese Guzman, Christopher Bryant, Sarah McGuire, Jessie Kennedy, Wei-Hung Chen, Agnes Hajduczki, Thembi Mdluli, Anais Valencia-Ruiz, Mihret F Amare, Gary R Matyas, Mangala Rao, Morgane Rolland, John R Mascola, Stephen C De Rosa, M Juliana McElrath, David C Montefiori, Leonid Serebryannyy, Adrian B McDermott, Sheila A Peel, Natalie D Collins, M Gordon Joyce, Merlin L Robb, Nelson L Michael, Sandhya Vasan, Kayvon Modjarrad, EID-030 Study Group |
|
4. |
[Articles] Plasmodium ovale spp dhfr mutations associated with reduced susceptibility to pyrimethamine in sub-Saharan Africa: a retrospective genetic epidemiology and functional study |
Valentin Joste, Romain Coppée, Justine Bailly, Yann Rakotoarivony, Francine Ghislaine Toko Tchokoteu, Shany Achache, Bruno Pradines, Gilles Cottrell, Frédéric Ariey, Nimol Khim, Jean Popovici, Toshihiro Mita, Mirjam Groger, Michael Ramharter, Timothy Egbo, Dennis W Juma, Hoseah Akala, Sandrine Houzé, Jérôme Clain, Investigation Study Group |
|
5. |
[Comment] To vaccinate or not against highly pathogenic avian influenza? |
Krishna Prasad Acharya, Sarita Phuyal |
|
6. |
[Correspondence] Harmonising the measurement of neutralising antibodies against chikungunya virus: a path forward for licensing of new vaccines? |
Sally A Baylis, Ivana Knezevic, Neil M Almond |
|
7. |
[Articles] SARS-CoV-2 rapid antigen test sensitivity and viral load in newly symptomatic hospital employees in Berlin, Germany, December, 2020 to February, 2022: an observational study |
Leonie Meiners, Johanna Horn, Terry C Jones, Barbara Mühlemann, Marie Luisa Schmidt, Felix Walper, Peter Menzel, Rolf Schwarzer, Ruben Rose, Andi Krumbholz, Victor M Corman, Joachim Seybold, Christian Drosten |
|
8. |
[Correspondence] A rapid test using a single drop of blood to screen for schistosomiasis in non-endemic countries |
Zeno Bisoffi, Stefania Varani, Bianca Granozzi, Silvia Stefania Longoni, Margherita Ortalli |
|
9. |
[Comment] Borealpox (Alaskapox) virus: will there be more emerging zoonotic orthopoxviruses? |
Nicola Douglass |
|
10. |
[Articles] Streptococcus pyogenes carriage and infection within households in The Gambia: a longitudinal cohort study |
Edwin P Armitage, Gabrielle de Crombrugghe, Alexander J Keeley, Elina Senghore, Fatoumata E Camara, Musukoi Jammeh, Amat Bittaye, Haddy Ceesay, Isatou Ceesay, Bunja Samateh, Muhammed Manneh, Beate Kampmann, Claire E Turner, Adam Kucharski, Anne Botteaux, Pierre R Smeesters, Thushan I de Silva, Michael Marks, MRCG StrepA Study Group |
|
11. |
[Review] Developing biomarker assays to accelerate tuberculosis drug development: defining target product profiles |
Stephen H Gillespie, Andrew R DiNardo, Sophia B Georghiou, Wilber Sabiiti, Mikashmi Kohli, Ursula Panzner, Irina Kontsevaya, Norbert Hittel, Lieven J Stuyver, Jia Bin Tan, Reinout van Crevel, Christoph Lange, Thuong Nguyen Thuy Thuong, Jan Heyckendorf, Morten Ruhwald, Norbert Heinrich |
|
12. |
[Comment] Pooled profiling of natural Mycobacterium tuberculosis diversity: linking genes, bacterial behaviours, and clinical outcomes |
Lucas Boeck |
|
13. |
[Articles] Identification of bacterial determinants of tuberculosis infection and treatment outcomes: a phenogenomic analysis of clinical strains |
Sydney Stanley, Caitlin N Spaulding, Qingyun Liu, Michael R Chase, Dang Thi Minh Ha, Phan Vuong Khac Thai, Nguyen Huu Lan, Do Dang Anh Thu, Nguyen Le Quang, Jessica Brown, Nathan D Hicks, Xin Wang, Maximillian Marin, Nicole C Howard, Andrew J Vickers, Wiktor M Karpinski, Michael C Chao, Maha R Farhat, Maxine Caws, Sarah J Dunstan, Nguyen Thuy Thuong Thuong, Sarah M Fortune |
|
14. |
[Correspondence] Used antigenic devices as a matrix for molecular detection of respiratory viruses |
Jean-Michel Mansuy, Emma Da Horta, Camille Bréhin, Isabelle Claudet, Pauline Trémeaux |
|
15. |
[Articles] Effect of human H3N2 influenza virus reassortment on influenza incidence and severity during the 2017–18 influenza season in the USA: a retrospective observational genomic analysis |
Hsuan Liu, Kathryn Shaw-Saliba, Jason Westerbeck, David Jacobs, Katherine Fenstermacher, Chia-Yu Chao, Yu-Nong Gong, Harrison Powell, Zexu Ma, Thomas Mehoke, Amanda W Ernlund, Amanda Dziedzic, Siddhant Vyas, Jared Evans, Lauren M Sauer, Chin-Chieh Wu, Shu-Hui Chen, Richard E Rothman, Peter Thielen, Kuan-Fu Chen, Andrew Pekosz |
|
16. |
[Review] Probable extinction of influenza B/Yamagata and its public health implications: a systematic literature review and assessment of global surveillance databases |
Saverio Caini, Adam Meijer, Marta C Nunes, Laetitia Henaff, Malaika Zounon, Bronke Boudewijns, Marco Del Riccio, John Paget |
|
17. |
[Articles] Assessment of CD8+ T-cell mediated immunity in an influenza A(H3N2) human challenge model in Belgium: a single centre, randomised, double-blind phase 2 study |
Thomas G Evans, Flora Castellino, Monika Kowalik Dobczyk, Gwen Tucker, Ana Marie Walley, Katrin Van Leuven, Jelle Klein, Kathryn Rutkowski, Chris Ellis, Elizabeth Eagling-Vose, John Treanor, Carel van Baalen, Ella Filkov, Cyril Laurent, Juilee Thacker, Jason Asher, Armen Donabedian |
|
18. |
[Correspondence] Additional thoughts on group A streptococci |
Dingle Yu, Yuejie Zheng, George Fu Gao, Yonghong Yang |
|
19. |
[Articles] Artemether–lumefantrine with or without single-dose primaquine and sulfadoxine–pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, Mali |
Almahamoudou Mahamar, Merel J Smit, Koualy Sanogo, Youssouf Sinaba, Sidi M Niambele, Adama Sacko, Oumar M Dicko, Makonon Diallo, Seydina O Maguiraga, Yaya Sankaré, Sekouba Keita, Siaka Samake, Adama Dembele, Kjerstin Lanke, Rob ter Heine, John Bradley, Yahia Dicko, Sekou F Traore, Chris Drakeley, Alassane Dicko, Teun Bousema, Will Stone |
|
20. |
[Articles] Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study |
Susan Jackson, Julia L Marshall, Andrew Mawer, Raquel Lopez-Ramon, Stephanie A Harris, Iman Satti, Eileen Hughes, Hannah Preston-Jones, Ingrid Cabrera Puig, Stephanie Longet, Tom Tipton, Stephen Laidlaw, Rebecca Powell Doherty, Hazel Morrison, Robert Mitchell, Rachel Tanner, Alberta Ateere, Elena Stylianou, Meng-San Wu, Timothy P W Fredsgaard-Jones, Judith Breuer, Garth Rapeport, Vanessa M Ferreira, Fergus Gleeson, Andrew J Pollard, Miles Carroll, Andrew Catchpole, Christopher Chiu, Helen McShane, COV-CHIM01 study team |
|
21. |
[Articles] Association between anti-capsular IgG levels at birth and risk of invasive group B streptococcus disease in Finnish newborns: a retrospective case–control study |
Annika Saukkoriipi, Natalie C Silmon de Monerri, Maija Toropainen, Laura Lindholm, Riitta Veijola, Jorma Toppari, Mikael Knip, David Radley, Emily Gomme, Babalwa Jongihlati, Annaliesa S Anderson, Arto A Palmu, Raphael Simon |
|
22. |
[Articles] Spread of carbapenemase-producing Morganella spp from 2013 to 2021: a comparative genomic study |
Rémy A Bonnin, Elodie Creton, Amandine Perrin, Delphine Girlich, Cecile Emeraud, Agnès B Jousset, Mathilde Duque, Aymeric Jacquemin, Katie Hopkins, Pierre Bogaerts, Youri Glupczynski, Niels Pfennigwerth, Marek Gniadkowski, Antoni P A Hendrickx, Kim van der Zwaluw, Petra Apfalter, Rainer Hartl, Vendula Studentova, Jaroslav Hrabak, Gerald Larrouy-Maumus, Eduardo P C Rocha, Thierry Naas, Laurent Dortet |
|
23. |
[Correspondence] Blood transcriptomic analyses reveal persistent SARS-CoV-2 RNA and candidate biomarkers in post-COVID-19 condition |
Soraya Maria Menezes, Marc Jamoulle, Maria Paula Carletto, Leen Moens, Isabelle Meyts, Piet Maes, Johan Van Weyenbergh |
|
24. |
[Correspondence] Assessing the entire landscape of antifungal immune response to COVID-19-associated pulmonary aspergillosis |
Florian Reizine, Jean-Marc Tadié, Murielle Grégoire, Karin Tarte, Jean-Pierre Gangneux |
|
25. |
[Comment] Epidemiology of group A streptococcal infection: are we ready for a new scenario? |
Miriam Massese, Marilena La Sorda, Flavio De Maio, Antonio Gatto, Roberto Rosato, Valeria Pansini, Anya Caroselli, Barbara Fiori, Maurizio Sanguinetti, Antonio Chiaretti, Brunella Posteraro |
|
26. |
[Comment] Shared immunogenic epitopes between host entry and exit proteins from monkeypox and Alaskapox viruses |
Leonardo Pereira de Araújo, Evandro Neves Silva, Patrícia Paiva Corsetti, Leonardo Augusto de Almeida |
|
27. |
[Correspondence] Whole-genome sequencing unveils the outbreak of Mycoplasma pneumoniae in mainland China |
Yan Chen, Xi Li, Ying Fu, Yunsong Yu, Hua Zhou |
|
28. |
[Comment] Risks of releasing imperfect Wolbachia strains for arbovirus control |
Henrik Salje, Francis M Jiggins |
|
29. |
[Personal View] Integrating research on bacterial pathogens and commensals to fight infections—an ecological perspective |
Lisa Maier, Christoph Stein-Thoeringer, Ruth E Ley, Heike Brötz-Oesterhelt, Hannes Link, Nadine Ziemert, Samuel Wagner, Andreas Peschel |
|
30. |
[Personal View] The WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation |
Giacomo Casalini, Andrea Giacomelli, Spinello Antinori |
|
31. |
[Articles] Xpert MTB/RIF Ultra versus mycobacterial growth indicator tube liquid culture for detection of Mycobacterium tuberculosis in symptomatic adults: a diagnostic accuracy study |
Yingda L Xie, Christie Eichberg, Nchimunya Hapeela, Elizabeth Nakabugo, Irene Anyango, Kiranjot Arora, Jeffrey E Korte, Ronald Odero, Judi van Heerden, Widaad Zemanay, Samuel Kennedy, Pamela Nabeta, Mahmud Hanif, Camilla Rodrigues, Alena Skrahina, Wendy Stevens, Reynaldo Dietze, Xin Liu, Jerrold J Ellner, David Alland, Moses L Joloba, Samuel G Schumacher, Kimberly D McCarthy, Lydia Nakiyingi, Susan E Dorman |
|
32. |
[Review] Infectious diseases and the role of needle biopsy post-mortem |
Lucia Molinengo, Theodore Estrin-Serlui, Brian Hanley, Michael Osborn, Robert Goldin |
|
33. |
[Correspondence] Concerted efforts toward genomic surveillance of viral pathogens in immunocompromised individuals |
Matheus Filgueira Bezerra, Gabriel da Luz Wallau |
|
34. |
[Correspondence] Are low-income and middle-income countries being neglected in genomic surveillance of the emergence and spread of multidrug-resistant Enterobacterales? |
Dennis Nurjadi, Sébastien Boutin, Thirumalaisamy P Velavan |
|
35. |
[Articles] Seroprevalence of Bas-Congo virus in Mangala, Democratic Republic of the Congo: a population-based cross-sectional study |
Yannick Munyeku-Bazitama, Patient Okitale-Talunda, Takanari Hattori, Takeshi Saito, Boniface Pongombo Lombe, Hiroko Miyamoto, Akina Mori-Kajihara, Masahiro Kajihara, Agathe Bikupe Nkoy, Augustin Tshibwabwa Twabela, Justin Masumu, Steve Ahuka-Mundeke, Jean-Jacques Muyembe-Tamfum, Manabu Igarashi, Eun-sil Park, Shigeru Morikawa, Sheila Makiala-Mandanda, Ayato Takada |
|
36. |
[Correspondence] Distribution of IncX3 plasmids in bacteria |
Yu Feng, Zhiyong Zong |
|
37. |
[Correspondence] Distribution of IncX3 plasmids in bacteria – Authors’ reply |
Qiu E Yang, Shungui Zhou, Timothy R Walsh |
|
38. |
[Review] Impact of climate change and natural disasters on fungal infections |
Danila Seidel, Sebastian Wurster, Jeffrey D Jenks, Hatim Sati, Jean-Pierre Gangneux, Matthias Egger, Ana Alastruey-Izquierdo, Nathan P Ford, Anuradha Chowdhary, Rosanne Sprute, Oliver Cornely, George R Thompson, Martin Hoenigl, Dimitrios P Kontoyiannis |
|
39. |
[Review] Staphylococcus aureus colonisation and strategies for decolonisation |
Pipat Piewngam, Michael Otto |
|
40. |
[News] AI-assisted HIV case finding in Ukraine |
Ed Holt |
|
41. |
[News] Routine malaria vaccinations start in Africa |
Priya Venkatesan |
|
42. |
[Correspondence] Global emergence of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses with I223V and S247N mutations: implications for antiviral resistance monitoring |
Rhoda Cheuk-Ying Leung, Jonathan Daniel Ip, Lin-Lei Chen, Wan-Mui Chan, Kelvin Kai-Wang To |
|
43. |
[Comment] Multicentre, cross-sectional surveillance of Helicobacter pylori prevalence and antibiotic resistance to clarithromycin and levofloxacin in urban China using the string test coupled with quantitative PCR |
Liang Wang, Zhengkang Li, Chin Yen Tay, Barry J Marshall, Bing Gu, Guangdong Center for Quality Control of Clinical Gene Testing and Study Group of Chinese Helicobacter pylori Infection and Antibiotic Resistance Rates Mapping Project (CHINAR-MAP) |
|
44. |
[News] Remote First Nations communities face climate change pressures |
Georgina Kenyon |
|
45. |
[Correspondence] Mining Staphylococcus aureus genomic data for identifying fosfomycin resistance genes |
Yiyi Chen, Yueqin Hong, Lu Sun, Yunsong Yu, Yan Chen |
|
46. |
[Correspondence] Comprehensive examination of travel-related antimicrobial resistance and the gut microbiome |
Yu Sun, Xi Fu |
|
47. |
[Correspondence] Pneumonia outbreaks due to re-emergence of Mycoplasma pneumoniae |
Patrick M Meyer Sauteur, Michael L Beeton, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group |
|
48. |
[Correspondence] The omicron BA.2.86 subvariant as a new serotype of SARS-CoV-2 |
Pei Du, Chunli Wu, Shixiong Hu, Rui Fan, George Fu Gao, Qihui Wang |
|
49. |
[Correspondence] Resurgence of Mycoplasma pneumonia by macrolide-resistant epidemic clones in China |
Heng Li, Shengkai Li, Huajiang Yang, Zhengrong Chen, Zhemin Zhou |
|